STIMULAN® is the first and only calcium matrix approved as an antibiotic carrier for use in bone and soft tissue • Distribution established with leader in German orthopaedic market Keele, UK, 7 December 2021 – Biocomposites, an international medical devices company that engineers, manufactures and markets world leading products for use in infection management in bone […]
Oegstgeest, December 7, 2021 – ISA’s very own Chief Scientific Officer, Cornelis “Kees” Melief, M.D., Ph.D., will be presenting key learnings in cancer vaccine development in an educational session at the ESMO Immune-Oncology Congress 2021, taking place on 8th – 11th December 2021 in Geneva, Switzerland and online. Read more…
Co-founded with renowned immunologist Professor Caetano Reis e Sousa of the Francis Crick Institute First UK-based ATP portfolio company NEW YORK and LONDON, December 7, 2021—ATP (Apple Tree Partners), a leader in life sciences venture capital, today announced the launch of Adendra Therapeutics Ltd. (“Adendra”), a company that will discover and develop treatments for cancers and autoimmune diseases […]
Underscores the Company’s ambition to harness the power of ultrasound in precision therapeutics amplification. OSLO/LONDON: 6 DECEMBER, 2021: Exact Therapeutics AS (“EXACT-Tx”, or “the Company” Euronext Growth: EXTX), a clinical-stage precision health company evaluating Acoustic Cluster Therapy (ACT®) across multiple therapeutic areas, today is delighted to announce the appointment of Anders Wold to its Board […]
Leucid will work with Lonza on the Cocoon® Platform for Leucid Bio’s Phase I/II clinical studies with its lead candidate, LEU-011, for the treatment of platinum resistant ovarian cancer Leucid will utilise the Cocoon® Platform through to commercial manufacturing. London, UK – 2 December 2021 – Leucid Bio (“Leucid” or the “Company”), a biotech company pioneering […]
